BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17602815)

  • 1. Assessment of skin absorption and irritation potential of arachidonic acid and glyceryl arachidonate using in vitro diffusion cell techniques.
    Eppler AR; Kraeling ME; Wickett RR; Bronaugh RL
    Food Chem Toxicol; 2007 Nov; 45(11):2109-17. PubMed ID: 17602815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo comparison of dermal irritancy of jet fuel exposure using EpiDerm (EPI-200) cultured human skin and hairless rats.
    Chatterjee A; Babu RJ; Klausner M; Singh M
    Toxicol Lett; 2006 Dec; 167(2):85-94. PubMed ID: 17049765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols.
    Kanikkannan N; Singh M
    Int J Pharm; 2002 Nov; 248(1-2):219-28. PubMed ID: 12429475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tandem repeated irritation in aged skin induces distinct barrier perturbation and cytokine profile in vivo.
    Angelova-Fischer I; Becker V; Fischer TW; Zillikens D; Wigger-Alberti W; Kezic S
    Br J Dermatol; 2012 Oct; 167(4):787-93. PubMed ID: 22578221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of salicylic acid from acne treatment products into and through skin: role of solution and ingredient properties and relationships to irritation.
    Rhein L; Chaudhuri B; Jivani N; Fares H; Davis A
    J Cosmet Sci; 2004; 55(1):65-80. PubMed ID: 15037921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of occlusive and unocclusive exposure to xylene and benzene on skin irritation and molecular responses in hairless rats.
    Chatterjee A; Babu RJ; Ahaghotu E; Singh M
    Arch Toxicol; 2005 May; 79(5):294-301. PubMed ID: 15902427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants.
    Müller-Decker K; Heinzelmann T; Fürstenberger G; Kecskes A; Lehmann WD; Marks F
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):59-67. PubMed ID: 9875300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of damaged skin barrier induced by subclinical irritation on the sequential irritant contact dermatitis.
    Yan-yu W; Xue-min W; Yi-Mei T; Ying C; Na L
    Cutan Ocul Toxicol; 2011 Dec; 30(4):263-71. PubMed ID: 21774626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
    Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
    J Pharm Pharmacol; 2003 May; 55(5):593-601. PubMed ID: 12831501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final report of the amended safety assessment of Glyceryl Laurate, Glyceryl Laurate SE, Glyceryl Laurate/Oleate, Glyceryl Adipate, Glyceryl Alginate, Glyceryl Arachidate, Glyceryl Arachidonate, Glyceryl Behenate, Glyceryl Caprate, Glyceryl Caprylate, Glyceryl Caprylate/Caprate, Glyceryl Citrate/Lactate/Linoleate/Oleate, Glyceryl Cocoate, Glyceryl Collagenate, Glyceryl Erucate, Glyceryl Hydrogenated Rosinate, Glyceryl Hydrogenated Soyate, Glyceryl Hydroxystearate, Glyceryl Isopalmitate, Glyceryl Isostearate, Glyceryl Isostearate/Myristate, Glyceryl Isostearates, Glyceryl Lanolate, Glyceryl Linoleate, Glyceryl Linolenate, Glyceryl Montanate, Glyceryl Myristate, Glyceryl Isotridecanoate/Stearate/Adipate, Glyceryl Oleate SE, Glyceryl Oleate/Elaidate, Glyceryl Palmitate, Glyceryl Palmitate/Stearate, Glyceryl Palmitoleate, Glyceryl Pentadecanoate, Glyceryl Polyacrylate, Glyceryl Rosinate, Glyceryl Sesquioleate, Glyceryl/Sorbitol Oleate/Hydroxystearate, Glyceryl Stearate/Acetate, Glyceryl Stearate/Maleate, Glyceryl Tallowate, Glyceryl Thiopropionate, and Glyceryl Undecylenate.
    Int J Toxicol; 2004; 23 Suppl 2():55-94. PubMed ID: 15513825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of skin barrier competence on SLS and water-induced IL-1alpha expression.
    Gibbs S; Vietsch H; Meier U; Ponec M
    Exp Dermatol; 2002 Jun; 11(3):217-23. PubMed ID: 12102660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro human skin irritation test for evaluation of medical device extracts.
    Casas JW; Lewerenz GM; Rankin EA; Willoughby JA; Blakeman LC; McKim JM; Coleman KP
    Toxicol In Vitro; 2013 Dec; 27(8):2175-83. PubMed ID: 23999410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in barrier impairment and inflammation of human skin as determined by sodium lauryl sulphate penetration rate.
    de Jongh CM; Jakasa I; Verberk MM; Kezic S
    Br J Dermatol; 2006 Apr; 154(4):651-7. PubMed ID: 16536807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo percutaneous absorption of retinol from cosmetic formulations: significance of the skin reservoir and prediction of systemic absorption.
    Yourick JJ; Jung CT; Bronaugh RL
    Toxicol Appl Pharmacol; 2008 Aug; 231(1):117-21. PubMed ID: 18511092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and irritancy of enhancers on the in-vitro and in-vivo percutaneous absorption of curcumin.
    Fang JY; Hung CF; Chiu HC; Wang JJ; Chan TF
    J Pharm Pharmacol; 2003 Aug; 55(8):1175. PubMed ID: 12956910
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of methyl substitution of benzene on the percutaneous absorption and skin irritation in hairless rats.
    Ahaghotu E; Babu RJ; Chatterjee A; Singh M
    Toxicol Lett; 2005 Dec; 159(3):261-71. PubMed ID: 16087301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of EpiDerm full thickness-300 (EFT-300) as an in vitro model for skin irritation: studies on aliphatic hydrocarbons.
    Mallampati R; Patlolla RR; Agarwal S; Babu RJ; Hayden P; Klausner M; Singh MS
    Toxicol In Vitro; 2010 Mar; 24(2):669-76. PubMed ID: 19720135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential.
    Perkins MA; Osborne R; Rana FR; Ghassemi A; Robinson MK
    Toxicol Sci; 1999 Apr; 48(2):218-29. PubMed ID: 10353313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antioxidant activity and in vivo efficacy of topical formulations containing vitamin C and its derivatives studied by non-invasive methods.
    Campos PM; Gonçalves GM; Gaspar LR
    Skin Res Technol; 2008 Aug; 14(3):376-80. PubMed ID: 19159387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.